Allied Corp. Share Price

ALID

US0191141078

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 17:24:55 16/01/2026 GMT			5-day change	1st Jan Change
0.0111 ^USD	-.--%		+1,109,900.00%	+2,120.00%

07-31	Allied Corp. Announces Resignation of Paul Bullock from COO and Director Role, Effective July 27, 2026	CI
07-31	Allied Corp. Announces Resignation of Paul Bullock from Interim CFO Role, Effective July 27, 2026	CI

Allied Corp. is an international medical cannabis production company. The Company is engaged in researching, creating, and producing targeted cannabinoid health solutions. It focuses on the development of Colombian produced medicinal cannabis for patients with conditions potentially suitable for treatment. Such conditions include anxiety, insomnia, anorexia, chronic pain, epilepsy, chemotherapy-induced nausea and vomiting, post-traumatic stress disorder (PTSD), Parkinsonâ€™s disease, Touretteâ€™s syndrome, irritable bowel syndrome (IBS) and spasticity associated with multiple sclerosis (MS) and spinal cord injury (SCI). Its core hemp-derived cannabidiol (CBD) brands are Tactical Relief Brand, Equilibrium Bio and MaXXa. The Tactical Relief brand's flagship product is a hemp-derived CBD tincture for sale in the United States. The Equilibrium Bio brand is primarily focused on hydration and recovery areas. The MaXXa brand develops natural CBD-infused cosmetics and beauty products.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
06/08/26	US$0.000001	-.--%	200

Real-time OTC Markets

More quotes

Income Statement and Estimates

More financial data

Market Cap	1.3M 1.13M 1.05M 967K 1.82M 124M 1.84M 12.35M 4.84M 62.17M 4.89M 4.79M 206M	P/E 2023	-2.13x	P/E 2024	-2.52x
Enterprise Value	7.55M 6.53M 6.1M 5.6M 10.52M 719M 10.69M 71.55M 28.05M 360M 28.35M 27.73M 1.19B	EV / Sales 2023	394,366,816x	EV / Sales 2024	171,944,593x
Free-Float	100%	Yield 2023 *	-	Yield 2024	-

07-31	Allied Corp. Announces Resignation of Paul Bullock from COO and Director Role, Effective July 27, 2026	CI
07-31	Allied Corp. Announces Resignation of Paul Bullock from Interim CFO Role, Effective July 27, 2026	CI
01-26	Mali takes 51% stake in China-backed local explosives venture	RE
05/02/25	Allied Corp. Announces Resignation of Calum Hughes as Chief Executive Officer	CI
05/02/25	Allied Corp. Announces Resignation of Calum Hughes as Director	CI
14/01/25	Allied Corp. Reports Earnings Results for the First Quarter Ended November 30, 2024	CI
16/12/24	Allied Corp. Reports Earnings Results for the Full Year Ended August 31, 2024	CI
15/12/24	Allied Corp. Auditor Raises 'Going Concern' Doubt	CI
18/11/24	Allied Corp. Completes 30Kg Shipment to Portuguese Channel Partner, Initiating United Kingdom Supply Contract	CI
16/10/24	Allied Colombia S.A.S. Enters into Forward Purchase Agreement with CanPoland Spolka Akeyina and Blossom Genetics Lda	CI
13/09/24	Allied Corp. Announces the Cessation of Ryan Maarschalk as Chief Financial Officer	CI
07/08/24	Allied Corp. announced that it has received $0.5 million in funding	CI
18/07/24	Allied Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2024	CI

07-31	Allied Provides Corporate Update	AQ
25/02/25	Allied Corp Strengthens Leadership Team to Drive Execution and Global Expansion	AQ
21/01/25	Allied Corp Announces Strategic Decision to Voluntarily Cease Quotation and SEC Registration	AQ
18/12/24	Allied : Amendment to Annual Report (Form 10-K/A)	PU
16/12/24	Allied : Annual Report (Form 10-K)	PU

1 week	0		0.01
1 month	0		0.01
Current year	0		0.01
1 year	0		0.01
3 years	0		0.26
5 years	0		2.15
10 years	0		4.5

Manager	Title	Age	Since
Paul James Bullock DFI	Director of Finance/CFO	-	-
Radka Milanova CTO	Chief Tech/Sci/R&D Officer	71	-
James Smeeding PRN	Corporate Officer/Principal	-	01/05/2020

Allied Corp. Share Price

Stocks

ALID

US0191141078

Pharmaceuticals

Valuation: Allied Corp.

Chart: Allied Corp.

Latest news : Allied Corp.

Press Releases: Allied Corp.

Quotes and Performance

Course Extremes

Managers and Directors: Allied Corp.

Latest insider transactions

Recreational Pharmaceuticals

Financials

Company Profile

Quotes

Income Statement and Estimates

1 week	+1,109,900.00%
Current month	+1,109,900.00%
1 month	+1,109,900.00%
3 months	+1,109,900.00%
6 months	+1,109,900.00%
Current year	+2,120.00%

Director	Title	Age	Since
Paul James Bullock BRD	Director/Board Member	-	-
James Smeeding BRD	Director/Board Member	-	01/05/2020
Abdul Nnyenje BRD	Director/Board Member	-	20/10/2024

Date	Insider	Type	Main position	Quantity	% Market Cap.
25/04/23	James Robinson	Buy	Director	80,000	0.0824%
22/09/20	Calum Hughes	Buy	Chief Executive Officer	10,000	0.0118%
22/09/20	Calum Hughes	Other	Chief Executive Officer	0	0%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ALLIED CORP.	-.--%	+1,109,900.00%	-.--%	-95.55%	117
CURALEAF HOLDINGS, INC.	+0.15%	+4.35%	+79.11%	-8.16%	2.46B
TRULIEVE CANNABIS CORP.	-2.78%	+1.16%	+61.14%	+118.48%	1.68B
VIREO GROWTH INC.	+1.78%	+8.33%	-41.15%	+172.38%	506M
LEEF BRANDS INC.	-3.85%	-10.71%	0.00%	0.00%	54.81M
Average	-0.94%	+0.63%	+19.82%	+37.43%	940.77M
Weighted average by Cap.	-0.77%	+3.46%	+58.83%	+56.66%

	2023	2024
Net sales	0.07 0.06 0.06 0.05 0.1 6.86 0.1 0.68 0.27 3.44 0.27 0.26 11.37	0.1 0.08 0.08 0.07 0.13 9.16 0.14 0.91 0.36 4.59 0.36 0.35 15.17
Net income	-10.68M -9.24M -8.62M -7.91M -14.88M -1.02B -15.11M -101M -39.65M -509M -40.08M -39.21M -1.68B	-3.98M -3.44M -3.21M -2.95M -5.54M -379M -5.63M -37.68M -14.77M -190M -14.93M -14.6M -627M
Net Debt	5.65M 4.89M 4.56M 4.19M 7.88M 538M 8M 53.55M 20.99M 270M 21.22M 20.76M 892M	6.25M 5.41M 5.05M 4.63M 8.71M 595M 8.84M 59.2M 23.21M 298M 23.46M 22.95M 986M